In contrast to other approaches, we believe the new payload payload capacity and ability to induce a broad immune response will enable us to include a wide range of patient - specific epitopes, thereby addressing the shortcoming of other approaches that require a more narrow selection due to
finite vector space and / or antigenic competition.